Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade
Anti-thyroglobulin antibodies (TgAb) and/or anti-thyroid peroxidase antibodies (TPOAb) positivity at baseline is a risk marker for thyroid immune-related adverse events (thyroid-irAEs) in anti-programmed cell death-1 antibody (PD-1-Ab) treatment; however, it is unknown if TgAb and TPOAb titers are a...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Japan Endocrine Society
2024-05-01
|
| Col·lecció: | Endocrine Journal |
| Matèries: | |
| Accés en línia: | https://www.jstage.jst.go.jp/article/endocrj/71/5/71_EJ23-0480/_html/-char/en |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
